What's new

Human medicines European public assessment report (EPAR): Leqembi, Lecanemab, Status: Opinion

Human medicines European public assessment report (EPAR): Leqembi, Lecanemab, Status: Opinion

Feb 28, 2025 - 13:44
 0
Human medicines European public assessment report (EPAR): Leqembi, Lecanemab, Status: Opinion
Human medicines European public assessment report (EPAR): Leqembi, Lecanemab, Status: Opinion
Read More

Tags:

Previous Article

Summary of opinion: Prevymis, 27/02/2025 Positive

Next Article

Summary of opinion: Supemtek Tetra (previously Supemtek), 27/02/2025 Positive

Related Posts

EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9 May 2025, 09:45 (CEST) to 9 May 2025, 16:00 (CEST)

EMA Open Door Day, European Medicines Agency, Amsterdam...

Feb 18, 2025  0

European Medicines Agency post-authorisation procedural...

Feb 18, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – July 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 July 2025, 10:00 (CEST) to 23 July 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0